A second booster? It’s time scientists shift focus to vaccines with long-lived antibody response

It has become increasingly clear that the second booster does not provide long-lasting protection against breakthrough infections.

Prakash Nagarkatti, The Conversation

 & 

Mitzi Nagarkatti, The Conversation

· Apr 18, 2022 · 11:30 pm

Is Omicron nature’s way of curbing the pandemic?

The variant has spread so efficiently and quickly, causing milder disease, that it has led many people to wonder: Is Omicron a vaccine of sorts?

Prakash Nagarkatti, The Conversation

 & 

Mitzi Nagarkatti, The Conversation

· Jan 29, 2022 · 07:30 pm